Novavax, Inc. and FUJIFILM Diosynth Biotechnologies announced today an agreement to manufacture bulk drug substance for Novavax’ COVID-19 vaccine candidate.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed